MILAN: Small and mid-sized Indian pharmaceutical firms at CPHI Worldwide on Tuesday said they are seeing more orders move from China, particularly for drug intermediates, as Western buyers diversify supply chains, though some cautioned that India still depends on Chinese raw materials and cannot yet match its prices.
CPHI is a major global business-to-business platform for the pharmaceutical industry, bringing together drug manufacturers, API suppliers, Contract Development and Manufacturing Organizations (CDMOs), contract manufacturers, formulation companies and procurement teams.
